| Literature DB >> 27088858 |
Lara Planas-Paz1, Vanessa Orsini1, Luke Boulter2, Diego Calabrese3, Monika Pikiolek1, Florian Nigsch1, Yang Xie4, Guglielmo Roma1, Adriana Donovan4, Patricia Marti1, Nicolau Beckmann1, Michael T Dill3, Walter Carbone1, Sebastian Bergling1, Andrea Isken1, Matthias Mueller1, Bernd Kinzel1, Yi Yang4, Xiaohong Mao4, Thomas B Nicholson4, Raffaella Zamponi4, Paola Capodieci4, Reginald Valdez4, Daniel Rivera4, Andreas Loew4, Chinweike Ukomadu4, Luigi M Terracciano5, Tewis Bouwmeester1, Feng Cong4, Markus H Heim3, Stuart J Forbes6, Heinz Ruffner1, Jan S Tchorz1.
Abstract
LGR4/5 receptors and their cognate RSPO ligands potentiate Wnt/β-catenin signalling and promote proliferation and tissue homeostasis in epithelial stem cell compartments. In the liver, metabolic zonation requires a Wnt/β-catenin signalling gradient, but the instructive mechanism controlling its spatiotemporal regulation is not known. We have now identified the RSPO-LGR4/5-ZNRF3/RNF43 module as a master regulator of Wnt/β-catenin-mediated metabolic liver zonation. Liver-specific LGR4/5 loss of function (LOF) or RSPO blockade disrupted hepatic Wnt/β-catenin signalling and zonation. Conversely, pathway activation in ZNRF3/RNF43 LOF mice or with recombinant RSPO1 protein expanded the hepatic Wnt/β-catenin signalling gradient in a reversible and LGR4/5-dependent manner. Recombinant RSPO1 protein increased liver size and improved liver regeneration, whereas LGR4/5 LOF caused the opposite effects, resulting in hypoplastic livers. Furthermore, we show that LGR4(+) hepatocytes throughout the lobule contribute to liver homeostasis without zonal dominance. Taken together, our results indicate that the RSPO-LGR4/5-ZNRF3/RNF43 module controls metabolic liver zonation and is a hepatic growth/size rheostat during development, homeostasis and regeneration.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27088858 DOI: 10.1038/ncb3337
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824